BlackRock Fund Advisors’s Acorda Therapeutics ACOR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$81M	Buy	35,917 +5,224	+17%	+$12.4M	0.01%	1361
2016 Q3	$76.9M	Buy	30,693 +2,162	+8%	+$6.45M	0.02%	1283
2016 Q2	$87.3M	Buy	28,531 +598	+2%	+$1.94M	0.02%	1082
2016 Q1	$88.7M	Buy	27,933 +1,347	+5%	+$5.59M	0.02%	1057
2015 Q4	$136M	Buy	26,586 +287	+1%	+$1.25M	0.03%	727
2015 Q3	$83.7M	Buy	26,299 +1,080	+4%	+$4.19M	0.02%	1043
2015 Q2	$101M	Buy	25,219 +190	+0.8%	+$734K	0.02%	988
2015 Q1	$100M	Buy	25,029 +1,535	+7%	+$7.03M	0.02%	1006
2014 Q4	$115M	Buy	23,494 +1,823	+8%	+$7.82M	0.03%	819
2014 Q3	$88.1M	Sell	21,671 -432	-2%	-$1.62M	0.02%	939
2014 Q2	$89.4M	Sell	22,103 -1,187	-5%	-$4.84M	0.03%	964
2014 Q1	$106M	Buy	23,290 +521	+2%	+$2.11M	0.03%	802
2013 Q4	$79.8M	Buy	22,769 +785	+4%	+$3.06M	0.02%	1022
2013 Q3	$90.2M	Buy	21,984 +2,683	+14%	+$11.6M	0.03%	839
2013 Q2	$76.4M	Buy	+19,301	New	+$79.5M	0.03%	852